Venture Capital News: Breaking Venture Capital News, Comments and Articles. - Page: 4

07:09 EDT 24th May 2015 | BioPortfolio

Venture Capital News - Page: 4RSS

Read the latest Venture Capital News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Venture Capital.

Search or Follow Our Venture Capital - Page: 4 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Venture Capital - Page: 4 News.

Showing "venture capital" News Articles 76 to 100 of 7,500+

Thursday 21st May 2015

RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference

Clinical trial at the University of British Columbia now recruiting patients VANCOUVER, May 21, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: REPCF), a clinical stage regenerative medicine company focused on the development of autologous cell therapies, announced today an upcoming poster presentation at the International Society for Cellular Therapy (ISCT) on RepliCel's au...

Wednesday 20th May 2015

Green Cross Juventas Investment Shows Gene Therapy Appetite

South Korea's Green Cross Holdings has invested in the clinical-stage U.S. biotech firm Juventas Therapeutics in a bid to diversify into the cell and gene therapy sector. Along with Posco Capital, Green Cross led a $7.5 million investment in the Clev...

GLOBAL BIOENERGIES: Cristal Union and Global Bioenergies have formed a joint venture to build and operate France's first bio-sourced isobutene production plant

EVRY and PARIS, May 21, 2015 (GLOBE NEWSWIRE) -- Cristal Union and Global Bioenergies are announcing today that they have formed IBN-One, a joint venture to build and operate the first plant in France converting renewable resources into isobutene. IBN-One is a société anonyme (limited liability corporation) with share capital of €1,000,000, jointly owned by Cristal Union and Global Bioenergie...

Till Capital Announces Nasdaq Listing

HAMILTON, Bermuda, May 21, 2015 (GLOBE NEWSWIRE) -- Till Capital Ltd. (TSX-V:TIL) (the "Company" or "Till"), a Bermuda domiciled company, is pleased to announce that effective Tuesday, May 26th, 2015, the Company's shares will begin trading on the Nasdaq Capital Market under the ticker symbol "TIL". "We are extremely pleased to be listed on the Nasdaq Stock Market, an important step in our over...

Tribute Pharmaceuticals Announces Acquisition of U.S. Rights to Fibricor(R) and Commercial Expansion into U.S. Market

MILTON, ONTARIO -- (Marketwired) -- 05/21/15 -- Tribute Pharmaceuticals Canada Inc. (OTCQX:TBUFF)(TSX VENTURE: TRX) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the U.S., is pleased to announce that its wholly owned subsidiary, Tribute Pharmaceuticals Internationa...

Horizon Technology Finance Provides $2.5 Million Venture Loan to Powerhouse Dynamics

FARMINGTON, Conn. and NEWTON, Mass., May 21, 2015 (GLOBE NEWSWIRE) -- Horizon Technology Finance Corporation (Nasdaq:HRZN) ("Horizon"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services and cleantech industries, announced today it has closed a $2.5 million ...

Simavita Limited: Results of Special Meeting

SYDNEY, AUSTRALIA -- (Marketwired) -- 05/21/15 -- Simavita Limited ("Simavita" or the "Company") (TSX VENTURE: SV)(ASX: SVA) is pleased to announce the results of the Special Meeting of the Company's share/CDI holders which was held at 10.00 am today (Australian Eastern time) in North Sydney, Australia. All four resolutions that were put before the shareholders were passed on a show of hands. D...

The flight of the oryx

(Inderscience Publishers) Qatar's capital city, Doha, is set to emerge as a major knowledge hub, with its educated, high-tech workforce and its international connectivity. However, the lack of a cohesive plan for development and the mobility of that ...

Fitch Affirms Cigna's Ratings; Outlook Stable

Fitch Ratings has affirmed Cigna Corp's (Cigna) Issuer Default Rating (IDR) at 'A-' and unsecured senior debt ratings at 'BBB+'. In addition, Insurer Financial Strength (IFS) ratings of various Cigna subsidiaries were affirmed at 'A+'. The Rating Outlooks are Stable. A complete list of rating actions follows at the end of this release. KEY RATING ...

Press Ganey Announces Pricing of Initial Public Offering

Press Ganey Holdings, Inc. today announced the pricing of its initial public offering of 8,900,000 shares of common stock at a public offering price of $25.00 per share, before underwriting discounts. All of the common stock is being offered by Press Ganey. In addition, Press Ganey has granted the underwriters a 30-day option to purchase up to an additiona...

CORRECTING and REPLACING Three Leaf Ventures Opens Midwest Office; Managing Director Speaks at Michigan Growth Capital Symposium

First paragraph, first sentence of release should read: Three Leaf Ventures, an affiliate of The Broe Group established to invest in progressive healthcare technology companies, is opening an office in Ann Arbor, MI to gain exposure to the growing opportunities that exist in the Midwest and East Coast regions (instead of: Three Leaf Ventures, a wholly-ow...

Three Leaf Ventures Opens Midwest Office; Managing Director Speaks at Michigan Growth Capital Symposium

Three Leaf Ventures, a wholly-owned subsidiary of The Broe Group established to invest in progressive healthcare technology companies, is opening an office in Ann Arbor, MI to gain exposure to the growing opportunities that exist in the Midwest and East Coast regions. As part of Three Leaf’s introduction to the market, Managing Director Sean Kearn...

Myomo gets $5mm in Series B-1 financing

Myomo Inc. (myoelectric technology to help patients recover motor function following a neurological event) raised $5mm in Series B-1 financing led by Mountain Group Capital and including returning backers.

RegenxBio raises $70.5M series D

Gene therapy company RegenxBio Inc. (Rockville, Md.) raised $70.5 million in an oversubscribed series D round led by new investor Vivo Capital and existing investors Venrock and Brookside Capital. Other investors included Janus Capital, Jennison Asso...

The Smart Cube and Quant Insight Launch a New Web-Based Investment Analytics Solution – Improves Decisions, Efficiency and Reduces Costly Trade Errors

This web-based research solution helps the investment industry make smarter, more data-driven financial decisions for optimal outcomes, returns and reduction of errors CHICAGO, IL (PRWEB) May 20, 2015 The Smart Cube, a global professional services firm specializing in custom research and analytics, today announced that it has formed Quant Insight(QI), a research company that innovatively relates ...

Onxeo: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at April 30, 2015

Regulatory News: Pursuant to article L.233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l'Autorité des Marchés Financiers (Regulation of...

GE speeds up target for GE Capital finance asset sales

May 20 (Reuters) - General Electric Co expects to unload about $100 billion in GE Capital assets this year, up from its target of $90 billion previously, according to a presentation for investors on Wednesday.

MPM Capital appoints Pablo J. Cagnoni, M.D., former Onyx Pharmaceuticals President, as Managing Director and CEO of MPM immunotherapy portfolio company Vesuvius.

MPM Capital announces the appointment of former President of Onyx Pharmaceuticals Pablo J. Cagnoni, M.D. as Managing Director (MD). In addition to serving as an MPM MD, Dr. Cagnoni is a co-founder of Vesuvius, an MPM-founded cancer immunotherapy company, and has taken on the role of President and Chief Executive Officer. Over of the course ...

10 Indiana Startups Receive $200,000 Through Elevate Purdue Foundry Fund

Ten Purdue-affiliated companies each received $20,000 in the newest round of funding of the First-Tier Black Awards from the Elevate Purdue Foundry Fund to support startup growth. "We had 23 applications for this second round of support since this fund was created last year. The selection process was highly competitive, and this caused our commit...

Tyme, Inc. Appoints Industry Veteran Robert Dickey IV as Chief Financial Officer

Tyme, Inc. (OTC QB:TYMI), a research and development company focused on developing drug candidates for the treatment of cancer, has appointed Robert Dickey IV to serve as its Chief Financial Officer (CFO). Most recently CFO of NeoStem, Inc. Mr. Dickey is a life sciences industry veteran and former investment banker with C-level and senior leadership experi...

Select Medical Corporation's Proposed Acquisition of Concentra Inc. through Joint Venture with Welsh Carson Receives Antitrust Clearance

MECHANICSBURG, Pa., May 20, 2015 /PRNewswire/ -- Select Medical Corporation ("Select") (NYSE: SEM) today announced that the Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976, as amended, applicable to the acquisition of Concentra Inc. ("Concentra") by MJ Acquisition Corporation, a joint venture th...

Results from Post-Market Study of the Direct Flow Medical Aortic Heart Valve System Demonstrate Consistently Positive Outcomes at 30 Days

Direct Flow Medical®, Inc., an innovative structural heart company, today announced 30-day outcomes from the DISCOVER post-market registry that demonstrate excellent real world results for the Direct Flow Medical Transcatheter Aortic Valve System consistent with the ground-break

Svelte Medical Systems Announces Updates to Clinical Program

World’s First Drug-Eluting Coronary Stent-on-a-Wire Demonstrates Sustained Clinical Results, 0% Stent Thrombosis in DIRECT II Randomized, Controlled Study; Plans for IDE Study Revealed Svelte Medical Systems, Inc. today reported 1-year clinical results from the DIRECT II study were similar to those seen at 6-months, with non-inferiority clearly estab...

CohBar Announces Commencement of Trading on the OTCQX Marketplace

CohBar, Inc. (OTCQX: CWBR and TSX-V: COB.U), an innovative biotechnology company focused on developing mitochondria-based therapeutics for diseases associated with aging, announced that its shares will begin trading today on the OTCQX® Best marketplace in the U.S. under the symbol “CWBR.” CohBar, a Delaware corporation based in California, began filin...

China Diabetes Management Devices Market Growth to be Driven by Rise in Sedentary Lifestyle and Life Expectancy and Patient Compliant Technologies Especially for Insulin Pump and CGM

LONDON and NEW YORK, May 20, 2015 /PRNewswire/ -- China, with 100 million diabetics has already outpaced other nations in terms of number of diabetics. Further, the market is estimated to grow many times as a large proportion of the population is pre-diabetic who may become diabetic in the near future. The China Diabetes Management Devices market comprises continuous glucose monitors (CGM), SMBG ...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks